FDA-Drug2026-08-19Class IIPROCESSING DEFECT

Shoolin Pharma Chem tadalafil USP powder recalled for CGMP manufacturing deviations

OTHERNationwide distributionDrugs

What this means

The FDA identified current good manufacturing practice (CGMP) deviations during an inspection of Shoolin Pharma Chem LLP's facility in India. The company manufactures tadalafil USP powder (active pharmaceutical ingredient) intended for prescription compounding use. One batch (TLF2506001, expiring May 31, 2028) totaling 20 kg was distributed nationwide in the USA.

  • If you are a licensed pharmacy or compounding facility that received this batch, quarantine it immediately and do not use it.
  • Contact Shoolin Pharma Chem LLP or your supplier for instructions on return or disposal.
  • Verify any compounded medications made from this batch and consult with the prescribing physician if concerned.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

CGMP Deviations:Noted during FDA inspection

Intended for
Adults
Illnesses reported
None reported
Sold states
Distributed Nationwide in the USA
Affected count
20 KG, 40 X 0.500KG(500gm) bags
Manufactured in
408 B/H Ratnamani Tubes, Block/Survey No; Nr Maruti Inox, Kadi, India
Products
TADALAFIL USP, 0.500 KG, 0.500KG(500gm)-bag, Rx only, "For Prescription Compounding Only", Shoolin Pharma Chem LLP, Block/Survey no 408, B/H Ratnamani Tubes, Near Maruti Inox, Indrad, Kadi, Mahesania, Gujarat, 382715, India, (CAS NO 171596-29-5), NDC 85702-002-04.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0761-2026

More Shoolin Pharma Chem recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.